Clinical trial
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate…
NCT00003717 · St. Barnabas Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00003717 |
|---|---|
| Title | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer |
| Official title | A Phase II Trial of Weekly Paclitaxel Plus Oral Estramustine in Patients With Hormone Refractory Prostate Cancer |
| Lead sponsor | St. Barnabas Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | estramustine phosphate sodium, paclitaxel |
| Enrollment | 17 |
| Start date | Oct 1, 1998 |
| First posted | Apr 14, 2004 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: